Dowling & Yahnke’s Chimerix, Inc. CMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$124K Hold
64,055
0.01% 361
2022
Q2
$133K Buy
64,055
+10,000
+18% +$32.1K 0.01% 363
2022
Q1
$248K Hold
54,055
0.01% 340
2021
Q4
$348K Buy
54,055
+10,000
+23% +$60K 0.02% 299
2021
Q3
$273K Hold
44,055
0.02% 321
2021
Q2
$352K Hold
44,055
0.02% 291
2021
Q1
$425K Buy
44,055
+7,042
+19% +$64.6K 0.03% 264
2020
Q4
$179K Hold
37,013
0.01% 318
2020
Q3
$92K Hold
37,013
0.01% 300
2020
Q2
$115K Hold
37,013
0.01% 293
2020
Q1
$53K Hold
37,013
0.01% 286
2019
Q4
$75K Hold
37,013
0.01% 311
2019
Q3
$87K Buy
+37,013
New +$107K 0.01% 300

Other funds holding CMRX

Dowling & Yahnke's CMRX Position: Q3 2022 in Review

Dowling & Yahnke held its Chimerix, Inc. (CMRX) position steady in Q3 2022 at 64,055 shares worth $124K. The position accounts for 0.01% of the portfolio, ranked #361.

Dowling & Yahnke first reported a position in CMRX in Q3 2019 and has held it in 13 quarters since. The position peaked at $425K in Q1 2021. 118 funds tracked by Wall St. Rank hold CMRX as of Q3 2022.

  • Dowling & Yahnke held 64,055 shares of Chimerix, Inc. worth $124K as of Q3 2022.
  • Dowling & Yahnke left its Chimerix, Inc. share count unchanged in Q3 2022.
  • Chimerix, Inc. made up 0.01% of Dowling & Yahnke's portfolio in Q3 2022, its #361 holding.
  • Dowling & Yahnke first reported a position in Chimerix, Inc. in Q3 2019 and has held it in 13 quarters since.
  • Dowling & Yahnke's Chimerix, Inc. position peaked at $425K in Q1 2021.
  • 118 funds tracked by Wall St. Rank held Chimerix, Inc. as of Q3 2022.

Based on Dowling & Yahnke's 13F filing for Q3 2022, filed 3 Nov 2022.